Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Psiquiatría | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375 (Ramelteon) Tablet for Sublingual Administration (TAK-375SL Tablet) in the Treatment of Acute Depressive Episodes Associated With Bipolar I Disorder in Adult Patients Who Are on Lithium and/or Valproate
INTERVENTIONAL
Inicio: 1 de dic de 2011
ID: NCT01467700
Completado
Fase 3
ClinicalTrials.gov
A Phase III Randomized, Double-blind, Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Iclepertin Once Daily Over 26 Week Treatment Period in Patients With Schizophrenia (CONNEX-3)
INTERVENTIONAL
Inicio: 9 de ago de 2021
ID: NCT04860830
Completado
Fase 3
ClinicalTrials.gov
Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase 3 Study of the Efficacy and Safety of Quetiapine Fumarate and Lithium as Monotherapy for up to 104 Weeks Maintenance Treatment of Bipolar I Disorder in Adult Patients
INTERVENTIONAL
Inicio: 1 de mar de 2005
ID: NCT00314184
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Multi-Centre Study to Compare the Efficacy and Safety of Extended Release Quetiapine Fumarate (Seroquel XR TM) Tablets as Mono-Therapy or in Combination With Lithium in the Treatment of Patients With Acute Bipolar Depression
INTERVENTIONAL
Inicio: 1 de abr de 2009
ID: NCT00883493
Por invitación
Fase 3
ClinicalTrials.gov
Long-term, Safety Extension Study of OLZ/SAM in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
INTERVENTIONAL
Inicio: 22 de oct de 2021
ID: NCT04987229
Completado
Fase 2
ClinicalTrials.gov
A Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia
INTERVENTIONAL
Inicio: 1 de mar de 2003
ID: NCT00639483
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Open-Label, Parallel-Group, Randomized, Flexible Dose Study To Evaluate the Safety and Tolerability of Switching From Existing Atypical Antipsychotics to Bifeprunox in Subjects With Schizophrenia or Schizoaffective Disorder
INTERVENTIONAL
Inicio: 1 de dic de 2006
ID: NCT00347425
Terminado
Fase 3
ClinicalTrials.gov
A 6-Month, Open-Label, Flexible-Dosage (150 to 200 mg/Day) Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
INTERVENTIONAL
Inicio: 30 de abr de 2010
ID: NCT01121536
Completado
ClinicalTrials.gov
BIOMARKERS FOR DRUG SELECTION IN DEPRESSION: 3BD Test
OBSERVATIONAL
Inicio: 18 de ago de 2022
ID: NCT07269886
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (13 to 17 Years of Age)
INTERVENTIONAL
Inicio: 29 de ene de 2026
ID: NCT07288567
Completado
Fase 2
ClinicalTrials.gov
An Eight-Week, Multicenter, Double-Blind, Placebo- and Paroxetine-Controlled Study Evaluating the Efficacy, and Tolerability of Two Fixed Doses of SSR149415 (250 mg Bid and 100 mg Bid) in Patients With Major Depressive Disorder
INTERVENTIONAL
Inicio: 1 de ago de 2006
ID: NCT00361491
Completado
Fase 3
ClinicalTrials.gov
A Double-blind, Randomized, Active-controlled, Parallel-group Study of Paliperidone Palmitate 6-Month Formulation
INTERVENTIONAL
Inicio: 20 de nov de 2017
ID: NCT03345342
Completado
Fase 4
ClinicalTrials.gov
Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
INTERVENTIONAL
Inicio: 1 de ago de 2001
ID: NCT00036088
Desconocido
ClinicalTrials.gov
Multifactorial Approach to Dementia. Multicentric Study
OBSERVATIONAL
Inicio: 20 de may de 2023
ID: NCT05923307
Completado
Fase 3
ClinicalTrials.gov
A Phase III Randomized, Double-blind, Placebo-controlled, Parallel Group Trial to Examine the Efficacy and Safety of Iclepertin Once Daily Over 26 Week Treatment Period in Patients With Schizophrenia (CONNEX-2)
INTERVENTIONAL
Inicio: 24 de ago de 2021
ID: NCT04846881
Completado
ClinicalTrials.gov
Prevalence and Risk Factors in Unipolar Depression Patients Without Remission After One Antidepressant Trial: PANTHER Study
OBSERVATIONAL
Inicio: 1 de sept de 2013
ID: NCT01887639
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, 8-Week Double-Blind Acute Phase Followed By a 6-Month Continuation Phase (Open-Label Or Double-Blind) Study to Evaluate the Efficacy, Safety, and Tolerability of DVS SR Versus Escitalopram in Postmenopausal Women With Major Depressive Disorder
INTERVENTIONAL
Inicio: 1 de dic de 2006
ID: NCT00406640
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Multicenter, Double-Blind, Non-inferiority Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Subjects With Schizophrenia
INTERVENTIONAL
Inicio: 1 de may de 2012
ID: NCT01515423
Anterior
1
...
4
5
6
...
434
Siguiente
Filtros